5437-98-9COc1ccc(NC(=O)CC(C)=O)cc1SWAJJKROCOJICG-UHFFFAOYSA-N5437-98-9DTXSID7044689CHEMBL3185475安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
This chemical does not meet GHS hazard criteria for 80.6% (104 of 129) of all reports.
Warning
H302 (18.6%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 129 reports by companies from 5 notifications to the ECHA C&L Inventory.
Chemical: Butanamide, N-(4-methoxyphenyl)-3-oxo-
REACH registered substance: 4'-methoxyacetoacetanilide (EC: 226-615-6)
用途有機合成原料。
使用N-(4-Methoxyphenyl)-3-oxobutanamide is an intermediate in the synthesis of Tafenoquine-d3 Succinate is the labelled analog of Tatenoquine (T004760), a new 8-aminoquinoline with an improved therapeutic index and safety profile as compared to primaquine (P733500).Tafenoquine has the potential to become a widely used drug in the prevention and treatment of malaria infection and could replace some currently used drugs as resistant strains of Plasmodium species increase.
現在のフィルター条件では反応記録がありません。
読み込み中…
化学的特性WHITE TO VERY SLIGHTLY YELLOW POWDER